Gilead Sciences (GILD) Treasury Shares (2012 - 2025)

Gilead Sciences has reported Treasury Shares for 14 years, with the latest figure at $17.8 million in Q4 2025.

• For the quarter ending Q4 2025, Treasury Shares fell 18.35% year-over-year to $17.8 million; the trailing twelve-month figure through Dec 2025 stood at $17.8 million (down 18.35% YoY), and the FY2025 full-year result was $17.8 million, down 18.35% from the prior year.
• Treasury Shares for Q4 2025 stood at $17.8 million, down from $21.8 million in the prior quarter.
• The five-year high for Treasury Shares was $22.7 million in Q4 2023, with the low at $1.0 million in Q2 2022.
• Historically, Treasury Shares has averaged $9.6 million across 5 years, with a median of $7.0 million in 2021.
• Annual changes were most pronounced in 2021 — Treasury Shares surged 600.0% — and 2022, when it sank 85.71%.
• Gilead Sciences' Treasury Shares stood at $8.0 million in 2021, then jumped by 137.5% to $19.0 million in 2022, then grew by 19.47% to $22.7 million in 2023, then dropped by 3.96% to $21.8 million in 2024, then slipped by 18.35% to $17.8 million in 2025.
• The last three Treasury Shares figures came in at $17.8 million (Q4 2025), $21.8 million (Q4 2024), and $4.0 million (Q3 2024), per Business Quant data.